131 related articles for article (PubMed ID: 9048763)
1. Identification of heparin-binding domains in the amyloid precursor protein of Alzheimer's disease by deletion mutagenesis and peptide mapping.
Clarris HJ; Cappai R; Heffernan D; Beyreuther K; Masters CL; Small DH
J Neurochem; 1997 Mar; 68(3):1164-72. PubMed ID: 9048763
[TBL] [Abstract][Full Text] [Related]
2. A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth.
Small DH; Nurcombe V; Reed G; Clarris H; Moir R; Beyreuther K; Masters CL
J Neurosci; 1994 Apr; 14(4):2117-27. PubMed ID: 8158260
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the high affinity heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP) and its enhancement by zinc(II).
Multhaup G; Mechler H; Masters CL
J Mol Recognit; 1995; 8(4):247-57. PubMed ID: 8588942
[TBL] [Abstract][Full Text] [Related]
4. Expression and analysis of heparin-binding regions of the amyloid precursor protein of Alzheimer's disease.
Mok SS; Sberna G; Heffernan D; Cappai R; Galatis D; Clarris HJ; Sawyer WH; Beyreuther K; Masters CL; Small DH
FEBS Lett; 1997 Oct; 415(3):303-7. PubMed ID: 9357988
[TBL] [Abstract][Full Text] [Related]
5. Identification and regulation of the high affinity binding site of the Alzheimer's disease amyloid protein precursor (APP) to glycosaminoglycans.
Multhaup G
Biochimie; 1994; 76(3-4):304-11. PubMed ID: 7819340
[TBL] [Abstract][Full Text] [Related]
6. Interaction between the zinc (II) and the heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP).
Multhaup G; Bush AI; Pollwein P; Masters CL
FEBS Lett; 1994 Nov; 355(2):151-4. PubMed ID: 7982489
[TBL] [Abstract][Full Text] [Related]
7. Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain.
Furukawa K; Sopher BL; Rydel RE; Begley JG; Pham DG; Martin GM; Fox M; Mattson MP
J Neurochem; 1996 Nov; 67(5):1882-96. PubMed ID: 8863493
[TBL] [Abstract][Full Text] [Related]
8. Affinity purification of proteoglycans that bind to the amyloid protein precursor of Alzheimer's disease.
Williamson TG; Nurcombe V; Beyreuther K; Masters CL; Small DH
J Neurochem; 1995 Nov; 65(5):2201-8. PubMed ID: 7595508
[TBL] [Abstract][Full Text] [Related]
9. Secreted form of amyloid beta/A4 protein precursor (APP) binds to two distinct APP binding sites on rat B103 neuron-like cells through two different domains, but only one site is involved in neuritotropic activity.
Ninomiya H; Roch JM; Jin LW; Saitoh T
J Neurochem; 1994 Aug; 63(2):495-500. PubMed ID: 7913487
[TBL] [Abstract][Full Text] [Related]
10. The role of extracellular matrix in the processing of the amyloid protein precursor of Alzheimer's disease.
Small DH; Nurcombe V; Clarris H; Beyreuther K; Masters CL
Ann N Y Acad Sci; 1993 Sep; 695():169-74. PubMed ID: 8239278
[TBL] [Abstract][Full Text] [Related]
11. Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I.
Beher D; Hesse L; Masters CL; Multhaup G
J Biol Chem; 1996 Jan; 271(3):1613-20. PubMed ID: 8576160
[TBL] [Abstract][Full Text] [Related]
12. Solution conformation and heparin-induced dimerization of the full-length extracellular domain of the human amyloid precursor protein.
Gralle M; Oliveira CL; Guerreiro LH; McKinstry WJ; Galatis D; Masters CL; Cappai R; Parker MW; Ramos CH; Torriani I; Ferreira ST
J Mol Biol; 2006 Mar; 357(2):493-508. PubMed ID: 16436282
[TBL] [Abstract][Full Text] [Related]
13. Secreted glypican binds to the amyloid precursor protein of Alzheimer's disease (APP) and inhibits APP-induced neurite outgrowth.
Williamson TG; Mok SS; Henry A; Cappai R; Lander AD; Nurcombe V; Beyreuther K; Masters CL; Small DH
J Biol Chem; 1996 Dec; 271(49):31215-21. PubMed ID: 8940123
[TBL] [Abstract][Full Text] [Related]
14. Frame-shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid beta40.
van Dijk R; Fischer DF; Sluijs JA; Sonnemans MA; Hobo B; Mercken L; Mann DM; Hol EM; van Leeuwen FW
J Neurochem; 2004 Aug; 90(3):712-23. PubMed ID: 15255950
[TBL] [Abstract][Full Text] [Related]
15. A 127-kDa protein (UV-DDB) binds to the cytoplasmic domain of the Alzheimer's amyloid precursor protein.
Watanabe T; Sukegawa J; Sukegawa I; Tomita S; Iijima K; Oguchi S; Suzuki T; Nairn AC; Greengard P
J Neurochem; 1999 Feb; 72(2):549-56. PubMed ID: 9930726
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein.
Rossjohn J; Cappai R; Feil SC; Henry A; McKinstry WJ; Galatis D; Hesse L; Multhaup G; Beyreuther K; Masters CL; Parker MW
Nat Struct Biol; 1999 Apr; 6(4):327-31. PubMed ID: 10201399
[TBL] [Abstract][Full Text] [Related]
17. Mutants of metal binding site M1 in APP E2 show metal specific differences in binding of heparin but not of sorLA.
Dienemann C; Coburger I; Mehmedbasic A; Andersen OM; Than ME
Biochemistry; 2015 Apr; 54(15):2490-9. PubMed ID: 25835329
[TBL] [Abstract][Full Text] [Related]
18. The role of heparan sulfate proteoglycans in the pathogenesis of Alzheimer's disease.
Small DH; Williamson T; Reed G; Clarris H; Beyreuther K; Masters CL; Nurcombe V
Ann N Y Acad Sci; 1996 Jan; 777():316-21. PubMed ID: 8624106
[TBL] [Abstract][Full Text] [Related]
19. Soluble amyloid-β precursor protein binds its cell surface receptor in a cooperative fashion with glypican and syndecan proteoglycans.
Reinhard C; Borgers M; David G; De Strooper B
J Cell Sci; 2013 Nov; 126(Pt 21):4856-61. PubMed ID: 23986479
[TBL] [Abstract][Full Text] [Related]
20. Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice.
Li S; Hou H; Mori T; Sawmiller D; Smith A; Tian J; Wang Y; Giunta B; Sanberg PR; Zhang S; Tan J
Sci Rep; 2015 Jun; 5():11322. PubMed ID: 26091071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
